Who is sponsoring NCT01504984?

NCT01504984 is sponsored by Samyang Biopharmaceuticals Corporation.

What drugs are being tested in NCT01504984?

Interventions: SYO-1126, Glivec film coated tab 4T(400mg).

What is the status of NCT01504984?

NCT01504984 is currently COMPLETED.

Last reviewed 2012-06-10 · How we verify

An Open-label, Randomized, Single Dose, Crossover Phase I Clinical Trial to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab., 4T (400mg) in Healthy Male Volunteers

NCT01504984 Phase 1 COMPLETED

The purpose of this study is to evaluate the pharmacokinetics equivalence and safety by comparing pharmacokinetics characteristics between the SYO-1126 and Glivec Film Coated tab 4T (400mg) when administered a single-dose to healthy male volunteers.

Details

Lead sponsor	Samyang Biopharmaceuticals Corporation
Phase	Phase 1
Status	COMPLETED
Enrolment	30
Start date	2012-03
Completion	2012-04

Conditions

Healthy

Interventions

SYO-1126
Glivec film coated tab 4T(400mg)

Primary outcomes

Pharmacokinetics of the AUCt SYO-1126 anf Glivec Film coated tab 4T(400mg) — 0-72hr
Pharmacokinetics of the Cmax SYO-1126 anf Glivec Film coated tab 4T(400mg) — 0-72hr

Countries

South Korea